The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new ...

Drug developers will be able to use alternatives to animal testing and possibly get new products to market faster under draft guidance issued Wednesday by the FDA. In a press release, officials said ...

Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling an openness to new approaches that haven’t been validated and the National ...

Stem Pharm, a Madison biotech startup, is using lab-created 3D "organoids" to develop a treatment for Alzheimer's disease. In April, the FDA and NIH announced plans to incentivize so-called "new ...

Testing products on animals became an industry standard in the cosmetic, chemical, and pharmaceutical industries nearly a century ago. Since that time, it has become clear that these tests cause ...

The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal antibody therapies and other drugs and biological products “with ...

In a Policy Forum, Chad Nelson and colleagues highlight the efforts of the U.S. Food and Drug Administration (FDA) in advancing alternative methods to reduce animal testing for regulatory use. Animal ...

There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific community: the need to phase out animal testing in biomedical research. The new ...

The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...

There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific community: the need to phase out animal testing in biomedical research. The new ...